查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1536674

痴呆症治疗市场，按适应症、按药物类别、按配销通路、按国家和地区划分 - 2024-2032 年行业分析、市场规模、市场份额和预测

Dementia Treatment Market, By Indication, By Drug Class, By Distribution Channel, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 322 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2023年失智症治疗市场规模为177.9021亿美元，2024年至2032年复合年增长率为7.80%。

痴呆症治疗市场-市场动态

痴呆症盛行率的上升和研发投资的增加预计将推动市场需求

受痴呆症影响的人数正在增加，尤其是老年人，这刺激了对有效治疗和护理解决方案的需求。对痴呆症症状的更高认识和改进的诊断工具有助于更早发现和治疗，从而促进市场成长。此外，政府和医疗保健组织的支持，包括为研发和公共卫生活动提供资金，有助于推动创新和获得治疗。因此，随着失智症盛行率的增加，对支持性照护服务的需求不断增长，包括家庭照护、长期照护设施和照护者支持，从而推动市场成长。

数位健康解决方案、远距医疗和个人化医疗等医疗技术的进步正在增强治疗选择并改善患者管理。此外，製药公司、生技公司和创投家对失智症研究和药物开发的大量投资也有助于市场的扩张。新药物和治疗方法的推出，特别是那些获得监管部门批准的药物和治疗方法，透过扩大治疗痴呆症的可用选择，有助于市场成长。

痴呆症治疗市场 - 主要见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032）每年将以 7.80% 左右的复合年增长率成长

根据适应症细分，由于阿兹海默症的盛行率增加，预计阿兹海默症 (AD) 失智症细分市场将在 2023 年显示最大的市场份额。

从药品类别细分来看，由于加兰他敏、多奈哌齐等处方率较高，胆碱酯酶抑制剂细分市场将成为 2023 年的主导药品类别。

根据配销通路细分，由于医院治疗的需求量很大，医院药房部门将在 2023 年成为领先的配销通路。

从地区来看，由于拥有顶级製药公司和先进的医疗设施，北美将成为 2023 年的主要收入来源。

痴呆症治疗市场-細項分析：

全球痴呆症治疗市场根据适应症、药物类别、配销通路和地区进行细分。

根据适应症，市场分为六类：阿兹海默症失智症、血管性失智症、路易氏体失智症、额颞叶失智症（FTD）、巴金森氏症失智症等。阿兹海默症痴呆细分市场占据主导地位。随着阿兹海默症新治疗药物的批准不断增加，促进了细分市场的成长。

根据药物类别，市场分为五类：胆碱酯酶抑制剂、NMDA 受体拮抗剂、MAO 抑制剂、组合药物等。预计组合药物领域在预测期内将以最高速度成长。

根据分销管道，市场分为三类：医院药房、零售药房和网路药房。医院药房领域在市场中占据主导地位，预计在预测期内将保持其较高的主导地位。随着医疗保健数位化的快速发展，预计线上药局将在预测期内以最快的速度成长。

痴呆症治疗市场 - 地理洞察

从地理来看，该市场广泛分布于北美、拉丁美洲、欧洲、亚太、中东和非洲等地区。北美在痴呆症治疗市场上占据主导地位。由于人口老化，患病率较高。在美国，近 650 万 65 岁及以上的人患有阿兹海默症。由于先进的医疗基础设施、高额医疗支出以及强劲的研发活动，北美在全球市场中占有重要份额。欧洲是痴呆症治疗市场的关键市场，在研究和医疗保健服务方面投资巨大。

痴呆症治疗市场-竞争格局：

痴呆症治疗市场竞争激烈，有许多公司参与开发和新型药物疗法。市场参与者非常重视阿兹海默症的研究和创新治疗方法。公司越来越多地投资于个人化医疗方法，以根据患者的个人情况量身定制治疗方案。与学术机构和其他公司的策略联盟致力于增强研究能力并加快药物开发。

最新进展：

2024年1月，卫材株式会社和百健（Biogen）公司核准Leqembi用于治疗AD失智症引起的轻度认知障碍。

2023年5月，礼来公司表示，一项3期临床研究的积极结果表明，donanemab显着减缓了阿兹海默症的认知和功能衰退。

目录

第一章：痴呆症治疗市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 痴呆症治疗市场片段（按适应症）
    • 按药物类别分類的痴呆症治疗市场片段
    • 按配销通路分類的痴呆症治疗市场片段
    • 按国家/地区分類的痴呆症治疗市场片段
    • 按地区分類的痴呆症治疗市场片段
  • 竞争洞察

第 3 章：痴呆症治疗主要市场趋势

  • 痴呆症治疗市场驱动因素
    • 市场驱动因素的影响分析
  • 痴呆症治疗市场限制
    • 市场限制影响分析
  • 痴呆症治疗市场机会
  • 痴呆症治疗市场未来趋势

第 4 章：痴呆症治疗产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：失智症治疗市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：痴呆症治疗市场格局

  • 2023 年痴呆症治疗市占率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：痴呆症治疗市场 - 按适应症

  • 概述
    • 按指标分類的细分市场占有率分析
    • 阿兹海默症 痴呆
    • 血管性失智症
    • 路易氏体失智症
    • 额颞叶失智症 (FTD)
    • 帕金森氏症痴呆
    • 其他的

第 8 章：失智症治疗市场 - 按药物类别

  • 概述
    • 按药物类别分類的细分市场份额分析
    • 胆碱酯酶抑制剂
    • NMDA 受体拮抗剂
    • MAO抑制剂
    • 复方药物
    • 其他的

第 9 章：痴呆症治疗市场 - 按配销通路

  • 概述
    • 按配销通路分類的细分市场份额分析
    • 医院药房
    • 零售药房
    • 网路药房

第 10 章：失智症治疗市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美痴呆症治疗主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按指标）
    • 北美市场规模和预测（按药物类别）
    • 北美市场规模和预测（按配销通路）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲痴呆症治疗主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模与预测（按指标）
    • 欧洲市场规模和预测（按药物类别）
    • 欧洲市场规模和预测（按配销通路）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区痴呆症治疗主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（依指标）
    • 亚太地区市场规模和预测（按药物类别）
    • 亚太地区市场规模和预测（按配销通路）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲痴呆症治疗主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按指标）
    • 拉丁美洲市场规模与预测（按药物类别）
    • 拉丁美洲市场规模和预测（按配销通路）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲痴呆症治疗主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（依指标）
    • 中东和非洲市场规模及预测（按药物类别）
    • 中东和非洲市场规模及预测（按配销通路）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 11 章：主要供应商分析 - 痴呆症治疗产业

  • 竞争仪表板
  • 公司简介
    • Eli Lilly and Company
    • Biogen Inc.
    • Roche Holding AG
    • Novartis International AG
    • Johnson & Johnson
    • AstraZeneca PLC
    • Amylyx Pharmaceuticals
    • Cassava Sciences, Inc.
    • Lundbeck A/S
    • Otsuka Pharmaceutical Co., Ltd.
    • Sanofi SA
    • Pfizer Inc.
    • Merck & Co., Inc.
    • Takeda Pharmaceutical Company Limited
    • Eisai Co., Ltd.
    • Others

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
Product Code: ANV3523

REPORT HIGHLIGHT

Dementia Treatment Market size was valued at USD 17,790.21 Million in 2023, expanding at a CAGR of 7.80% from 2024 to 2032.

Dementia treatment focuses on managing symptoms, improving quality of life, and slowing the progression of the disease. Dementia treatment plans are often tailored to the individual and may require adjustments over time as the disease progresses.

Dementia Treatment Market- Market Dynamics

Growing prevalence of dementia and increased investment in research & development are expected to propel market demand

The number of individuals affected by dementia is increasing especially among older adults, which fuels demand for effective treatments and care solutions. Greater awareness of dementia symptoms and improved diagnostic tools lead to earlier detection and treatment, contributing to market growth. Further, support from governments and healthcare organizations, including funding for research and development and public health campaigns, helps drive innovation and access to treatments. Thus, As the prevalence of dementia increases, there is a growing need for supportive care services, including home care, long-term care facilities, and caregiver support, driving market growth.

Advances in medical technology, such as digital health solutions, telemedicine, and personalized medicine, are enhancing treatment options and improving patient management. Additionally, Significant investments from pharmaceutical companies, biotech firms, and venture capitalists into dementia research and drug development contribute to the expansion of the market. The introduction of new drugs and treatments, particularly those receiving regulatory approval, contributes to market growth by expanding available options for managing dementia.

Dementia Treatment Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 7.80% over the forecast period (2024-2032)

Based on Indication segmentation, the Alzheimer's disease (AD) dementia segment was predicted to show maximum market share in the year 2023, owing to the increased prevalence if Alzheimer's disease.

Based on Drug Class segmentation, the cholinesterase inhibitors segment was the leading drug class in 2023, due to high prescription rates of galantamine, donepezil, etc.

Based on Distribution Channel segmentation, the hospital pharmacy segment was the leading Distribution Channel in 2023, owing to the high need for hospital treatment.

On the basis of region, North America was the leading revenue generator in 2023, owing to presence of top pharmaceutical companies & advanced medical facilities.

Dementia Treatment Market- Segmentation Analysis:

The Global Dementia Treatment Market is segmented on the basis of Indication, Drug Class, Distribution Channel, and Region.

The market is divided into six categories based on Indication: Alzheimer's Disease Dementia, Vascular Dementia, Lewy Body Dementia, Frontotemporal Dementia (FTD), Parkinson's Disease Dementia, and others. The Alzheimer's Disease Dementia segment dominates the market. With the increasing approval of new therapeutics drugs in Alzheimer's boosting segment growth.

The market is divided into five categories based on Drug Class: cholinesterase inhibitors, NMDA receptor antagonists, MAO inhibitors, combination drugs, and others. The combination drugs segment is projected to grow at the highest rate over the forecast period.

The market is divided into three categories based on Distribution channels: hospital pharmacy, retail pharmacy, and online pharmacy. The hospital pharmacy segment dominates the market and is expected to maintain its high dominance during the forecast period. Online pharmacy is anticipated to grow at the fastest rate during the forecast period with the rapid digitalization in healthcare.

Dementia Treatment Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America dominates the Dementia Treatment market. High prevalence due to aging populations. In the U.S., nearly 6.5 million people aged 65 and older are living with Alzheimer's disease. North America holds a significant share of the global market due to advanced healthcare infrastructure, high healthcare expenditure, and robust research and development activities. Europe is a key market in the dementia treatment market with considerable investments in research and healthcare services.

Dementia Treatment Market- Competitive Landscape:

The dementia treatment market is highly competitive, with numerous companies involved in developing and novel drug therapies. Market players have a strong emphasis on Alzheimer's research and innovative treatments. Companies are increasingly investing in personalized medicine approaches to tailor treatments to individual patient profiles. Strategic alliances with academic institutions and other companies are focusing on enhancing research capabilities and speeding up drug development.

Recent Developments:

In January 2024, Eisai Co., Ltd. and Biogen got approval for Leqembi for the treatment of mild cognitive impairment due to AD dementia.

In May 2023, Eli Lilly stated the positive results of a phase-3 clinical study demonstrated that donanemab significantly slowed cognitive and functional decline in Alzheimer's disease.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL DEMENTIA TREATMENT MARKET KEY PLAYERS

  • Eli Lilly and Company
  • Biogen Inc.
  • Roche Holding AG
  • Novartis International AG
  • Johnson & Johnson
  • AstraZeneca PLC
  • Amylyx Pharmaceuticals
  • Cassava Sciences, Inc.
  • Lundbeck A/S
  • Otsuka Pharmaceutical Co., Ltd.
  • Sanofi S.A.
  • Pfizer Inc.
  • Merck & Co., Inc.
  • Takeda Pharmaceutical Company Limited
  • Eisai Co., Ltd.
  • Others

GLOBAL DEMENTIA TREATMENT MARKET, BY INDICATION- MARKET ANALYSIS, 2019-2032

  • Alzheimer's Disease Dementia
  • Vascular Dementia
  • Lewy Body Dementia
  • Frontotemporal Dementia (FTD)
  • Parkinson Disease Dementia
  • Others

GLOBAL DEMENTIA TREATMENT MARKET, BY DRUG CLASS- MARKET ANALYSIS, 2019-2032

  • Cholinesterase Inhibitors
  • NMDA Receptor Antagonist
  • MAO Inhibitors
  • Combination Drug
  • Others

GLOBAL DEMENTIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL- MARKET ANALYSIS, 2019-2032

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

GLOBAL DEMENTIA TREATMENT MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Dementia Treatment Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Dementia Treatment Market Snippet by Indication
    • 2.1.2. Dementia Treatment Market Snippet by Drug Class
    • 2.1.3. Dementia Treatment Market Snippet by Distribution Channel
    • 2.1.4. Dementia Treatment Market Snippet by Country
    • 2.1.5. Dementia Treatment Market Snippet by Region
  • 2.2. Competitive Insights

3. Dementia Treatment Key Market Trends

  • 3.1. Dementia Treatment Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Dementia Treatment Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Dementia Treatment Market Opportunities
  • 3.4. Dementia Treatment Market Future Trends

4. Dementia Treatment Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Dementia Treatment Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Dementia Treatment Market Landscape

  • 6.1. Dementia Treatment Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Dementia Treatment Market - By Indication

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Indication, 2024 & 2032 (%)
    • 7.1.2. Alzheimer's Disease Dementia
    • 7.1.3. Vascular Dementia
    • 7.1.4. Lewy Body Dementia
    • 7.1.5. Frontotemporal Dementia (FTD)
    • 7.1.6. Parkinson Disease Dementia
    • 7.1.7. Others

8. Dementia Treatment Market - By Drug Class

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Drug Class, 2024 & 2032 (%)
    • 8.1.2. Cholinesterase Inhibitors
    • 8.1.3. NMDA Receptor Antagonist
    • 8.1.4. MAO Inhibitors
    • 8.1.5. Combination Drug
    • 8.1.6. Others

9. Dementia Treatment Market - By Distribution Channel

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Distribution Channel, 2024 & 2032 (%)
    • 9.1.2. Hospital Pharmacy
    • 9.1.3. Retail Pharmacy
    • 9.1.4. Online Pharmacy

10. Dementia Treatment Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Dementia Treatment Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Dementia Treatment Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Dementia Treatment Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Dementia Treatment Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Dementia Treatment Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Dementia Treatment Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Eli Lilly and Company
    • 11.2.2. Biogen Inc.
    • 11.2.3. Roche Holding AG
    • 11.2.4. Novartis International AG
    • 11.2.5. Johnson & Johnson
    • 11.2.6. AstraZeneca PLC
    • 11.2.7. Amylyx Pharmaceuticals
    • 11.2.8. Cassava Sciences, Inc.
    • 11.2.9. Lundbeck A/S
    • 11.2.10. Otsuka Pharmaceutical Co., Ltd.
    • 11.2.11. Sanofi S.A.
    • 11.2.12. Pfizer Inc.
    • 11.2.13. Merck & Co., Inc.
    • 11.2.14. Takeda Pharmaceutical Company Limited
    • 11.2.15. Eisai Co., Ltd.
    • 11.2.16. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Dementia Treatment Market: Indication Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Indication
  • TABLE Global Dementia Treatment Market, by Indication 2019-2032 (USD Million)
  • TABLE Dementia Treatment Market: Drug Class Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Drug Class
  • TABLE Global Dementia Treatment Market, by Drug Class 2019-2032 (USD Million)
  • TABLE Dementia Treatment Market: Distribution Channel Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Distribution Channel
  • TABLE Global Dementia Treatment Market, by Distribution Channel 2019-2032 (USD Million)
  • TABLE Dementia Treatment Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Dementia Treatment Market, by Region 2019-2032 (USD Million)
  • TABLE North America Dementia Treatment Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Dementia Treatment Market, by Indication, 2019-2032 (USD Million)
  • TABLE North America Dementia Treatment Market, by Drug Class, 2019-2032 (USD Million)
  • TABLE North America Dementia Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  • TABLE Europe Dementia Treatment Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Dementia Treatment Market, by Indication, 2019-2032 (USD Million)
  • TABLE Europe Dementia Treatment Market, by Drug Class, 2019-2032 (USD Million)
  • TABLE Europe Dementia Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  • TABLE Asia Pacific Dementia Treatment Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Dementia Treatment Market, by Indication, 2019-2032 (USD Million)
  • TABLE Asia Pacific Dementia Treatment Market, by Drug Class, 2019-2032 (USD Million)
  • TABLE Asia Pacific Dementia Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  • TABLE Latin America Dementia Treatment Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Dementia Treatment Market, by Indication, 2019-2032 (USD Million)
  • TABLE Latin America Dementia Treatment Market, by Drug Class, 2019-2032 (USD Million)
  • TABLE Latin America Dementia Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Dementia Treatment Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Dementia Treatment Market, by Indication, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Dementia Treatment Market, by Drug Class, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Dementia Treatment Market, by Distribution Channel, 2019-2032 (USD Million)

List of Figures

  • FIGURE Dementia Treatment Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2023
  • FIGURE Indication segment market share analysis, 2023 & 2032
  • FIGURE Indication segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Drug Class segment market share analysis, 2023 & 2032
  • FIGURE Drug Class segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Distribution Channel segment market share analysis, 2023 & 2032
  • FIGURE Distribution Channel segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Regional segment market share analysis, 2023 & 2032
  • FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE North America Dementia Treatment Market share and leading players, 2023
  • FIGURE Europe Dementia Treatment Market share and leading players, 2023
  • FIGURE Asia Pacific Dementia Treatment Market share and leading players, 2023
  • FIGURE Latin America Dementia Treatment Market share and leading players, 2023
  • FIGURE Middle East and Africa Dementia Treatment Market share and leading players, 2023
  • FIGURE North America market share analysis by country, 2023
  • FIGURE U.S. Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Canada Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Europe Dementia Treatment Market share analysis by country, 2023
  • FIGURE Germany Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Spain Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Italy Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE France Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE UK Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Russia Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Netherlands Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Sweden Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Poland Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of the Europe Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Asia Pacific Dementia Treatment Market share analysis by country, 2023
  • FIGURE India Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE China Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Japan Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE South Korea Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Australia Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Thailand Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Indonesia Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Philippines Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of APAC Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Dementia Treatment Market share analysis by country, 2023
  • FIGURE Brazil Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Mexico Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Argentina Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Colombia Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of LATAM Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Dementia Treatment Market share analysis by country, 2023
  • FIGURE Saudi Arabia Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE United Arab Emirates Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Israel Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Turkey Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Algeria Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Egypt Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of MEA Dementia Treatment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)